A
Aquestive Therapeutics, Inc. (AQST)
NGM – Real Time Price. Currency in USD
4.39
-0.08 (-1.68%)
At close: Jun 26, 2026, 4:00 PM EDT
4.40
+0.01 (0.23%)
After-hours: Jun 26, 2026, 7:58 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
4.39
-0.08 (-1.68%)
At close: Jun 26, 2026, 4:00 PM EDT
4.40
+0.01 (0.23%)
After-hours: Jun 26, 2026, 7:58 PM EDT
No Data
There are no news for this stock.
Total debt $133.6M significantly exceeds cash reserves ($110.7M), raising financial stability concerns
Total current assets $130.2M exceed Total current liabilities $31.8M, highlighting excellent liquidity
Debt-to-equity ratio (-3.9) is well below the industry average (-0.8), showcasing prudent financial management
Interest coverage ratio (-1.1x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$14.9M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 4.10 | 2.52 | 10 | |
| Quick ratio | 3.85 | 1.78 | 10 | |
| Debt to Equity | N/A | -0.80 | 1.0 | |
| Debt to Assets | 0.95 | 0.73 | 2.0 | |
| Interest coverage | -1.07 | -13.90 | 1.0 | |
| Weighted average score | 4.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 48M | 51M | 58M | 45M | 50M |
| Gross Profit | 28M | 30M | 40M | 27M | 32M |
| Operating Income | -42M | -15M | -31M | -70M | -56M |
| Net Income | -54M | -8M | -44M | -84M | -69M |
| EBITDA | -40M | -14M | -30M | -69M | -55M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 14.17 | 25 | 9.0 |
| Next quarter | -5.84 | 19.64 | 5.0 |
| Current year | 13.56 | 47.44 | 9.0 |
| Next year | 41.78 | 7.32 | 7.5 |
| Weighted average score | 7.6 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 11 | 74.71 | 73.08 | -73.69 | 7.0 |
| Y/Y | 65.67 | 64.86 | 70.83 | 36.87 | 10 |
| 3y average | -0.89 | -155.02 | -85.6 | -134.24 | 1.0 |
| 5y average | 0.39 | -93.72 | -45.75 | -61.66 | 1.3 |
| Weighted average score | 4.8 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |